Literature DB >> 11691495

Heart failure with preserved systolic function. A different natural history?

M Senni1, M M Redfield.   

Abstract

Three well-controlled epidemiology studies in the U.S. have reported that 40% of incident congestive heart failure (CHF) cases and 50% to 60% of prevalent CHF cases occur in the setting of preserved systolic function. This condition has been termed "diastolic heart failure" (DHF). Despite minor differences in the types of populations examined, these community-based studies have established DHF as a major health problem in the U.S., particularly among the elderly. Although extensive data are available concerning the natural history of CHF associated with reduced systolic dysfunction (systolic heart failure; SHF), the natural history of DHF is not well-characterized. Indeed, it remains unclear whether patients with DHF share the grim prognosis described for patients with SHF. In this review we examine the available studies comparing survival observed in patients with DHF to that observed in patients with SHF. Although there are insufficient data at present to make definitive conclusions, careful examination of the available studies raises the possibility that the natural history of patients with DHF may not be different from that observed in patients with CHF and reduced systolic function.

Entities:  

Mesh:

Year:  2001        PMID: 11691495     DOI: 10.1016/s0735-1097(01)01567-4

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  51 in total

1.  Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction.

Authors:  Sameer Ather; Wenyaw Chan; Biykem Bozkurt; David Aguilar; Kumudha Ramasubbu; Amit A Zachariah; Xander H T Wehrens; Anita Deswal
Journal:  J Am Coll Cardiol       Date:  2012-03-13       Impact factor: 24.094

2.  Congestion is the driving force behind heart failure.

Authors:  Maya Guglin
Journal:  Curr Heart Fail Rep       Date:  2012-09

3.  The natural history of preclinical diastolic dysfunction: a population-based study.

Authors:  Mark W Vogel; Joshua P Slusser; David O Hodge; Horng H Chen
Journal:  Circ Heart Fail       Date:  2012-01-25       Impact factor: 8.790

4.  [Guidelines for therapy of chronic heart failure].

Authors:  U C Hoppe; M Böhm; R Dietz; P Hanrath; H K Kroemer; A Osterspey; A A Schmaltz; E Erdmann
Journal:  Z Kardiol       Date:  2005-08

5.  Re: Determination of left ventricular filling pressure by new echocardiographic methods in patients with coronary artery disease.

Authors:  Leo H B Baur
Journal:  Int J Cardiovasc Imaging       Date:  2007-06-22       Impact factor: 2.357

Review 6.  Office management of patients with diastolic heart failure.

Authors:  Katina Tzanetos; Derek Leong; Robert C Wu
Journal:  CMAJ       Date:  2009-03-03       Impact factor: 8.262

7.  A randomized trial of home telemonitoring in a typical elderly heart failure population in North West London: results of the Home-HF study.

Authors:  Owais Dar; Jillian Riley; Callum Chapman; Simon W Dubrey; Stephen Morris; Stuart D Rosen; Michael Roughton; Martin R Cowie
Journal:  Eur J Heart Fail       Date:  2009-01-27       Impact factor: 15.534

8.  Comparison of medication practices in patients with heart failure and preserved versus those with reduced ejection fraction (from the Cardiovascular Research Network [CVRN]).

Authors:  Robert J Goldberg; Jerry H Gurwitz; Jane S Saczynski; Grace Hsu; David D McManus; David J Magid; David H Smith; Alan S Go
Journal:  Am J Cardiol       Date:  2013-02-01       Impact factor: 2.778

9.  Prevalence of suspected diastolic dysfunction in patients with a clinical diagnosis of congestive heart failure.

Authors:  Mohammad-Reza Movahed; Mastaneh Ahmadi-Kashani; Yuji Saito
Journal:  Heart Fail Rev       Date:  2005-12       Impact factor: 4.214

10.  Outcomes in ambulatory chronic systolic and diastolic heart failure: a propensity score analysis.

Authors:  Ali Ahmed; Gilbert J Perry; Jerome L Fleg; Thomas E Love; David C Goff; Dalane W Kitzman
Journal:  Am Heart J       Date:  2006-11       Impact factor: 4.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.